|
well
|
5
|
Resverlogix Corp.
|
Apr 05, 2021 09:52PM
|
|
otc zen
|
|
Zenith Epigenetics
|
Apr 06, 2021 06:17PM
|
|
Re: otc zen
|
|
Zenith Epigenetics
|
Apr 06, 2021 07:31PM
|
|
Re: otc zen
|
2
|
Zenith Epigenetics
|
Apr 06, 2021 11:09PM
|
|
Re: BOOM there it is
|
13
|
Resverlogix Corp.
|
Apr 08, 2021 10:51AM
|
|
GV on stock house
|
6
|
Resverlogix Corp.
|
Apr 08, 2021 11:18AM
|
|
Re: GV on stock house
|
5
|
Resverlogix Corp.
|
Apr 08, 2021 01:47PM
|
|
This late June meeting, warrants about to expire???
|
4
|
Resverlogix Corp.
|
Apr 09, 2021 11:34AM
|
|
Re: Insider Transactions - RSU/Deferred Shares
|
1
|
Resverlogix Corp.
|
Apr 11, 2021 01:24PM
|
|
Re: Zenith Presentation at AACR Meeting April 10-15
|
3
|
Zenith Epigenetics
|
Apr 11, 2021 02:24PM
|
|
Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
5
|
Resverlogix Corp.
|
Apr 12, 2021 08:34AM
|
|
Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
6
|
Resverlogix Corp.
|
Apr 12, 2021 08:44AM
|
|
Re: Zenith Presentation at AACR Meeting April 10-15
|
2
|
Zenith Epigenetics
|
Apr 12, 2021 10:03AM
|
|
Re: Zenith Presentation at AACR Meeting April 10-15
|
1
|
Zenith Epigenetics
|
Apr 12, 2021 10:46AM
|
|
Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
5
|
Resverlogix Corp.
|
Apr 12, 2021 07:10PM
|
|
Re: Volume
|
3
|
Zenith Epigenetics
|
Apr 13, 2021 01:37PM
|
|
Give us just one or two NR’s - money, partners & timeframe
|
9
|
Resverlogix Corp.
|
Apr 13, 2021 01:50PM
|
|
Re: Give us just one or two NR’s - money, partners & timeframe
|
6
|
Resverlogix Corp.
|
Apr 13, 2021 03:12PM
|
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
6
|
Resverlogix Corp.
|
Apr 14, 2021 10:45PM
|
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
8
|
Resverlogix Corp.
|
Apr 14, 2021 10:59PM
|
